JP Morgan Chase’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,500
Closed -$2.82M 7495
2023
Q3
$2.82M Buy
+100,500
New +$2.95M ﹤0.01% 3277
2019
Q2
Sell
-25,000
Closed -$912K 5750
2019
Q1
$912K Buy
+25,000
New +$826K ﹤0.01% 3862
2018
Q4
Sell
-169,800
Closed -$7.21M 5665
2018
Q3
$7.21M Sell
169,800
-30,300
-15% -$1.32M ﹤0.01% 2461
2018
Q2
$8.24M Buy
200,100
+91,100
+84% +$4.15M ﹤0.01% 2294
2018
Q1
$6.32M Buy
109,000
+89,000
+445% +$5.21M ﹤0.01% 2383
2017
Q4
$1.09M Buy
+20,000
New +$1.02M ﹤0.01% 3676

Other funds holding ALKS

JP Morgan Chase's ALKS Position: Q2 2026 in Review

JP Morgan Chase reduced its Alkermes (ALKS) stake by 94% in Q2 2026, selling an estimated $150M and leaving 262,721 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

JP Morgan Chase first reported a position in ALKS in Q2 2013 and has held it in 49 quarters since. The position peaked at $173M in Q1 2025. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • JP Morgan Chase held 262,721 shares of Alkermes worth $14.2M as of Q2 2026.
  • JP Morgan Chase sold 3,839,068 Alkermes shares in Q2 2026, an estimated $150M.
  • Alkermes made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2498 holding.
  • JP Morgan Chase first reported a position in Alkermes in Q2 2013 and has held it in 49 quarters since.
  • JP Morgan Chase's Alkermes position peaked at $173M in Q1 2025.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.